Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT-P10 vs Rituxan in Advanced Follicular Lymphoma
NCT02162771Phase 3Completed
- Sponsor
- Celltrion
- Start
- Jul 2014
- Primary completion
- Jan 2016
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of rituximab in follicular lymphoma (FL), sponsored by Celltrion. Started Jul 2014; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT02162771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02162771.